Meeting
2018 Genitourinary Cancers Symposium
Treatment patterns for metastatic hormone-sensitive prostate cancer (mHSPC) progressing after up-front docetaxel in combination with androgen deprivation therapy (D-ADT).
Authors
Pedro C. Barata
Cleveland Clinic, Cleveland, OH
Pedro C. Barata , Hamid Emamekhoo , Prateek Mendiratta , Dharmesh Gopalakrishnan , Vadim S. Koshkin , Allison Janine Tyler , Moshe Chaim Ornstein , Petros Grivas , Timothy D. Gilligan , Brian I. Rini , Christos Kyriakopoulos , Jorge A. Garcia
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer, Urothelial Carcinoma, and Penile, Urethral, and Testicular Cancers
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers
Sub Track
Prostate Cancer - Advanced Disease
Citation
J Clin Oncol 36, 2018 (suppl 6S; abstr 305)
DOI
10.1200/JCO.2018.36.6_suppl.305
Abstract #
305
Poster Bd #
B16
Abstract Disclosures
Similar Posters
Poster
2021 Genitourinary Cancers Symposium
SPOP mutations in prostate cancer: Clinical and genomic features.
First Author: Mari Nakazawa
Poster
2021 Genitourinary Cancers Symposium
Multi-institutional evaluation of the clinical outcomes and genomic correlates of African Americans with metastatic castration-sensitive prostate cancer (mCSPC).
First Author: Meredith MI Freeman
Poster
2019 Genitourinary Cancers Symposium
EphB4-EphrinB2 receptor-ligand pair as a novel target in prostate cancer (PC).
First Author: Sarmad Sadeghi
Poster
2016 Genitourinary Cancers Symposium
Treatment patterns after abiraterone acetate in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Post hoc analysis of COU-AA-302.
First Author: Thomas W. Flaig